AmbioPharm, a provider of peptide API CDMO services, made state-of-the-art upgrades to its AmbioPharm South Carolina headquarters, including increasing synthesis capacity. In a statement, the company said that in order to accommodate and support growth in late phase and commercial production, they have made recent installations including: • 1M high-performance liquid chromatography column (HPLC) • 1,000L lyophilizer • Tangential flow filtration system with centrifuge • Large walk in 2-8...